logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

Features of clinical manifestations and metabolism of connective tissue structures in teenagers with osteoarthrosis at the background o f hypermobile syndrome

[Pediatrics]
Elena Matvienko; Anna Letiago; Irina Grigoryevna Khmelevskaya; Nina Dmitrievna Krivdina; Natalya Sergeevna Razinkova; Alexandra Vladimirovna Serezhkina;

The aim of the work was to clarify clinical manifestations, to determine changes in the metabolism of connective tissue structures in adolescents with osteoarthritis on the background of hypermobil syndrome. 139 adolescents with osteoarthritis aged 12–18 years were examined. The main group consisted of 93 patients with osteoarthritis, which was formed on the background of hypermobil syndrome. The comparison group consisted of patients with OA without the presence of HMS. It was found that osteoarthritis in adolescents is secondary and develops against the background of hypermobil syndrome as a manifestation of systemic connective tissue dysplasia. It was determined that in adolescents with the activation of acid and alkaline phosphatases there are significant changes in the metabolism of proteoglycans and collagen, which is confirmed by the redistribution of glycosaminoglycan fractions in serum, increased excretion of uric acids and hydroxyproline.

Download

References:
1. Nasonov E. L., Nasonovа V. A. Rheumatology: national leadership. M .: GEOTAR-Media, 2010. (In Russ.).
2. Wang Y., Teichtahl A. J., Cicuttini F. M. Osteoarthritis year in review 2015: imaging. Osteoarthritis Cartilage. 2016;24(1):49-57. https://doi.org/10.1016/j.joca.2016.12.009
3. Zhang M., Wang J. Epigenetics and osteoarthritis. Genes. Dis. 2015;2(1):69-75. https://doi.org/10.1015/j.gendis.2015.12.005
4. Shevchenko N. S., Lebets I. S., Nelina I. N., Kashkalda D. A., Matvienko E. V., Letyago A. V. Pathogenetic significance of inflammation in osteoarthritis in adolescents with initial stages of the disease. Ukrainskij revmatologicheskij zhurnal. – Ukrainian rheumatological journal. 2010;1:50-54. (In. Ukr).
5. Dmitrieva L. A. Immunological aspects of the etiopathogenesis of coxarthrosis (literature review). Bulletin of the SSC of the RAMS. 2005;6:179-182. (In Russ.).
6. Fernandes J. C., Martel-Pelletier J., Pelletier J. P. The role of cytokines in osteoarthritis pathophysiology.Biorheology. 2002;39(2):237-246.
7. Lebets I. S., Matvienko E. V., Kostyurina N. A., Nelina I. N. Osteoarthritis and hypermobility. Travma. – Trauma. 2005;7:262-266. (In. Ukr).
8. Silvestri Е., Corazza А., Molfetta L., Garlaschi G. Metabolic bone changes in osteoarthritis: the role of imaging and pathogenetic interpretation. J. Biol. Regul. Homeost. Agents. 2015;29(3):737-743.
9. Tyurin A. V., Davletshin R. A., Farkhutdinov R. R., Zaripova R. M., Davletshin T. M. Features of the metabolism of the intercellular substance in patients with osteoarthritis and connective tissue dysplasia. Klinicist. – Clinician. 2014;2:33-38. (In Russ.). https://doi.org/10.17650/1818-8338-2014-2-33-38
10. Lafeber F. P., van Spil W. E. Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time. Osteoarthritis Cartilage. 2013;21(10):1452-1464. https://doi.org/10.1016/j.joca.2013.08.012
11. Stogov M. V., Ovchinnikov E. N., Sazonova N. V. Features of the metabolic status of patients of different age groups at the stages of osteoarthrosis of large joints. Uspekhi gerontologii. – Successes of gerontology.2015;28(1):86-90. (In Russ.).
12. Stogov M. V., Ovchinnikov E. N. Laboratory tests in preclinical diagnosis of osteoarthrosis. Analytical review. Genii ortopedii. – The genius of orthopedics. 2016;1:96-103. (In Russ.). https://doi.org/10.18019/1028-4427-2016-1-96-103
13. Garnero P., Delmas P. D. Biomarkers in osteoarthritis. Curr. Opin. Rheumatol. 2003;15(5):641-646.
14. Reijman А., Hazes J. M., Bierma-Zeinstra S. M., Koes B. W., Christgau S. A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum. 2004;50(8):2471-2478.
15. Henrotin Y., Addison S., Kraus V., Deberg M. Type II collagen markers in osteoarthritis: what do they indicate? Curr. Opin. Rheumatol. 2007;19(5):444-450.
16. Altman R., Alarton G., Appelrouth D. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1997;34:505- 514.
17. Kovalenko V. M., Bortkevich O. P. Osteoarthritis: A practical guide. 2nd ed., Pererab. and add. K.: Morion, 2005. (In. Ukr).
18. Beighton P. L. Solomon, Soskone C. L. Articular mobility in an African population. Ann. Rheum. Dis. 1973;32(5):413.
19. Kellgren J. H., Lawrence J. S. Radiologic assessment of osteoarthrosis. Ann. Rheum. Dis. 1957;16:496-501.

Keywords: osteoarthrosis, adolescents, hypermobile syndrome, proteoglycans, chondroitinsulfate, hydroxyproline


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy